SLDB

Solid Biosciences Inc.

Price

$9.74

return (12m)

67.93%

p/e

-6.30

p/bv

3.49

DIVIDEND YIELD

0.00%

SLDB price

Solid Biosciences

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment SLDB

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

14.72%

3 months

49.85%

1 year

67.93%

2 years

4.96%

5 years

-74.83%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals SLDB

Valuation

P/E

-6.30

Sector -4.38

Industry -4.38

P/BV

3.49

Sector 2.02

Industry 2.02

P/Revenue (PSR)

Sector -4.40

Industry -4.40

EV/EBITDA

-17.05

Sector -263.09

Industry -263.09

EV/EBIT

-16.93

Sector -702.90

Industry -702.90

P/EBITDA

-6.29

Sector -4.39

Industry -4.39

P/EBIT

-6.25

Sector -4.73

Industry -4.73

P/Total Assets

3.10

Sector 1.49

Industry 1.49

P/Net Current Assets

3.74

Sector -11.70

Industry -11.70

P/Working Capital

3.56

Sector -3.19

Industry -3.19

EPS

-1.44

Sector -2.14

Industry -2.14

BVPS

2.60

Sector 1.85

Industry 1.85

Efficiency

Gross Margin

0.00%

Sector 36.74%

Industry 36.74%

EBITDA Margin

Sector -16,244.81%

Industry -16,244.81%

EBIT Margin

Sector -4,202,541.34%

Industry -4,202,541.34%

Operating Margin

0.00%

Sector -38.22%

Industry -38.22%

Net Profit Margins

0.00%

Sector -39.69%

Industry -39.69%

Asset Turnover

0.00

Sector 0.03

Industry 0.03

Profitability

ROE

-55.37%

Sector -65.14%

Industry -65.14%

ROA

-49.24%

Sector -65.53%

Industry -65.53%

ROIC

-619.05%

Sector -2,103.35%

Industry -2,103.35%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

13.82

Sector 2.90

Industry 2.90

Net Debt / EBITDA

6.94

Sector -6.07

Industry -6.07

Net Debt / EBIT

6.89

Sector -8.26

Industry -8.26

Net Debt / Equity

-1.01

Sector -1.07

Industry -1.07

Gross Debt / Equity

0.00

Sector -0.05

Industry -0.05

Equity/Assets

0.89

Sector 0.41

Industry 0.41

Liabilities/Assets

0.11

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

23.47%

Sector -

Industry -

Fundamentals SLDB

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
SLDB Solid Biosciences Inc.	$9.74	61.53%	0.00%	-6.30	3.49	-55.37%	0.00%
JNJ Johnson & Johnson	$273.41	58.46%	2.02%	29.66	7.34	24.76%	21.48%
PFE Pfizer Inc.	$28.24	21.45%	6.54%	34.62	1.75	5.07%	6.80%
ABBV AbbVie Inc.	$265.97	33.11%	2.73%	70.02	-74.53	-106.44%	9.81%
NVO Novo Nordisk A/S	$46.48	-9.14%	4.09%	11.13	5.91	53.11%	35.32%
MRK Merck & Co. Inc.	$152.20	87.95%	2.45%	106.68	8.06	7.56%	4.77%
AZN AstraZeneca PLC	$164.95	4.92%	2.07%	22.98	4.77	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$67.61	46.95%	3.93%	14.06	5.85	41.59%	18.87%
ZTS Zoetis Inc.	$76.68	-48.52%	2.77%	11.89	9.88	83.10%	27.49%
REGN Regeneron Pharmaceuticals Inc.	$840.84	43.05%	0.45%	19.09	2.61	13.65%	27.86%
AMGN Amgen Inc.	$442.36	55.11%	2.39%	25.30	18.93	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$107.62	56.06%	0.00%	27.82	80.17	288.14%	24.86%
MCK McKesson Corporation	$853.71	27.85%	0.38%	22.42	-79.15	-352.96%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$552.06	41.60%	0.00%	29.26	6.36	21.76%	35.00%
CAH Cardinal Health Inc.	$234.85	58.85%	0.88%	31.61	-19.89	-62.92%	0.67%
HRMY Harmony Biosciences Holdings Inc.	$39.93	9.67%	0.00%	12.18	2.21	18.14%	18.89%
BIIB Biogen Inc.	$221.56	63.02%	0.00%	37.04	1.64	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

SLDB Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Solid Biosciences

Solid Biosciences Inc.

Average Investor10 user rating

4.0 (2 people)

United States

13 years

Founded: 2013

2018

Time since IPO - 8 years

70

Employees

Solid Biosciences Inc. (United States) is listed on the Nasdaq and has a market capitalization of $1.31 billion, with shareholders equity totaling $374.07 million.

The company employs approximately 70 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Solid Biosciences Inc. reported $- in revenue, generating net income of $-207.11 million.

Key financial metrics include a P/E ratio of -6.30, a price-to-book (P/B) ratio of 3.49, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker SLDB.

Market cap

$1.31 billion

Net worth

$374.07 million

$374,070,000.00

Assets

$420.58 million

$420,580,000.00

Total Shares Outstanding

144.00 million

144,000,000

Average Daily Trading Volume

$1.78 million

$1,780,397.64

Sector

Health Care

Industry

Biotechnology

SLDB

SLDB revenue and profits

Financial Results SLDB

DRAG THE FRAME TO SEE MORE DATA

SLDB cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$853.71 22,07% (12M)

P/E

22.42

0.38%

ROE

-352.96%

P/BV

-79.15

CAH - Cardinal Health

$234.85 55,51% (12M)

P/E

31.61

0.88%

ROE

-62.92%

P/BV

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12M)

P/E

29.66

2.02%

ROE

24.76%

P/BV

7.34

ABBV - AbbVie

$265.97 31,23% (12M)

P/E

70.02

2.73%

ROE

-106.44%

P/BV

-74.53

MRK - Merck & Co.

$152.20 86,97% (12M)

P/E

106.68

2.45%

ROE

7.56%

P/BV

8.06

AZN - AstraZeneca

$164.95 5,00% (12M)

P/E

22.98

2.07%

ROE

20.74%

P/BV

4.77

PFE - Pfizer

$28.24 21,16% (12M)

P/E

34.62

6.54%

ROE

5.07%

P/BV

1.75

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$853.71 22,07% (12 M)

P/L

22.42

0.38%

ROE

-352.96%

P/VP

-79.15

CAH - Cardinal Health

$234.85 55,51% (12 M)

P/L

31.61

0.88%

ROE

-62.92%

P/VP

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12 M)

P/L

29.66

2.02%

ROE

24.76%

P/VP

7.34

ABBV - AbbVie

$265.97 31,23% (12 M)

P/L

70.02

2.73%

ROE

-106.44%

P/VP

-74.53

MRK - Merck & Co.

$152.20 86,97% (12 M)

P/L

106.68

2.45%

ROE

7.56%

P/VP

8.06

AZN - AstraZeneca

$164.95 5,00% (12 M)

P/L

22.98

2.07%

ROE

20.74%

P/VP

4.77

PFE - Pfizer

$28.24 21,16% (12 M)

P/L

34.62

6.54%

ROE

5.07%

P/VP

1.75

Frequently Asked Questions

What is the price of Solid Biosciences (SLDB) today?

A cotação de Solid Biosciences (SLDB) hoje está em US$ 9.74, com uma variação de 67.93% em relação ao último ano. A cotação de Solid Biosciences (SLDB) iniciou o ano negociando na casa dos US$ 5.64 e hoje está em US$ 9.74. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Solid Biosciences (SLDB) e dados de ações do Ibovespa e mercados internacionais.

Quando Solid Biosciences (SLDB) paga dividendos?

Solid Biosciences (SLDB) não distribuiu dividendos no último ano.

Is Solid Biosciences (SLDB) a good investment?

Atualmente, Solid Biosciences (SLDB) está cotada a US$ 9.74, com um P/L de -6.30, representando um desvio de -256% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 67.93 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 67.93%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Solid Biosciences (SLDB) stock?

Investir em ações de Solid Biosciences (SLDB) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Solid Biosciences (SLDB) yield today?

A rentabilidade de Solid Biosciences (SLDB) foi de 14.72% no último mês, 67.93% no último ano e -74.83% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Solid Biosciences (SLDB) hoje, o investimento total seria de US$ 974.00, com base na cotação atual de US$ 9.74.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 1,635.64
Em 5 anos: US$ 245.16
Em 10 anos: US$ 974.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

SLDB

Solid Biosciences Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment SLDB

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING SLDB WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Solid Biosciences

Solid Biosciences Inc.

United States

13 years

2018

70

PROFIT X PRICE SLDB

Financial Results SLDB

SLDB cash flow

Asset, Revenue and Profit Growth - SLDB

SLDB balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions